Urgent Notice for Picard Medical Investors: Class Action Deadline Approaches

Important Update for Picard Medical Investors

As investors in Picard Medical, Inc. (NYSE: PMI) might already be aware, a significant opportunity is present for those affected by recent market activities to seek legal redress. A prominent national securities law firm, Faruqi & Faruqi, LLP, is actively investigating potential claims against the company, urging investors to take action before the looming deadline of April 13, 2026.

Background on the Situation

Following an alarming decline in share value of Picard Medical—witnessed during a crucial trading period from September 2, 2025, to October 31, 2025—investors have encountered substantial financial losses. A staggering drop of 59.8% in stock price was reported on October 24, 2025, as shares plummeted from $13.20 to $5.31. This incident, marking one of the company’s most significant one-day declines, has left many shareholders questioning the factors that contributed to such drastic market behavior.

The allegations brought forth allege that Picard Medical and its executives engaged in prohibited activities by disseminating misleading information about the company's financial standing, alongside failing to disclose details about a fraudulent stock promotion scheme. This scheme involved social media disinformation and the impersonation of financial experts, which ultimately contributed to the inflated stock price from which substantial numbers of shares were dumped.

Legal Rights and Actions

Faruqi & Faruqi's lead partner, James (Josh) Wilson, is spearheading this legal initiative aimed at providing a platform for affected investors to reclaim their losses. Shareholders who purchased stocks during the defined period are encouraged to contact the firm directly to discuss the ongoing legal strategies and their rights regarding joining the class action as lead plaintiffs. Interested parties can reach out to Wilson at either 877-247-4292 or 212-983-9330 (Ext. 1310).

The firm has indicated its commitment to ensuring that all investors know their rights and options amidst this unfolding situation. Any member of the plaintiff class may opt to participate by informing the court of their intention to take a more active role in the litigation, or alternatively, they can stay passive and await the outcomes without affecting their recovery terms.

Importance of Agency

Involvement in the class action serves dual objectives: not only can it facilitate reparations for affected parties, but it also brings awareness to deceptive market practices that compromise the integrity of investment landscapes. Moreover, Faruqi & Faruqi actively solicits information from whistleblowers, previous employees, and anyone with insights concerning Picard Medical's conduct, thereby broadening the investigatory scope to protect wider investor interests.

Take Action Now

For investors who have experienced setbacks or wish to better understand their options—be it discussions about the class action or general inquiries about the firm's practices—the urgency cannot be overstated. The approaching deadline is a decisive moment for many, and it could very well shape the financial futures of those involved.

To learn more about the allegations, legal processes, and your rights, please visit Faruqi & Faruqi's dedicated webpage. Here, you can also stay updated on ongoing developments and legal news relating to Picard Medical.

Let us remind you that timely action can be pivotal in discussing your stakes with competent legal counsel. With aid from competent legal representation like that of Faruqi & Faruqi, stakeholders stand a better chance of receiving justice in the face of corporate misleading actions. Stay informed, and don’t let this window of opportunity close without exploring potential recovery paths.